Literature DB >> 9282975

A multiplex polymerase chain reaction assay for the detection of Mycobacterium paratuberculosis DNA in Crohn's disease tissue.

M Al-Shamali1, I Khan, B Al-Nakib, F Al-Hassan, A S Mustafa.   

Abstract

BACKGROUND: Mycobacterium paratuberculosis is implicated as a possible cause of Crohn's disease. However, due to lack of an appropriate diagnostic method, this has been a subject of significant controversy. Our aim was therefore to develop a multiplex polymerase chain reaction (MPCR) for the detection of M. paratuberculosis DNA in Crohn's disease tissue.
METHODS: Biopsy samples were collected by endoscopic forceps from terminal ileum, and genomic DNA was isolated. M. paratuberculosis-specific marker genes were amplified by using the present MPCR method.
RESULTS: Here we report a new MPCR for detection of M. paratuberculosis DNA in Crohn's disease tissue. In this technique two genetic markers, IS900 and a newly described specific marker of MP2, were amplified in a single tube simultaneously. The method was evaluated using biopsy specimens from 10 Crohn's disease patients, 6 ulcerative colitis patients, and 21 irritable bowel syndrome patients. The patients were characterized by using standard clinical and histologic observations. The present MPCR method could not detect M. paratuberculosis DNA in the biopsy specimens. However, the marker genes were amplified from the samples that were spiked with M. paratuberculosis before DNA extraction. The marker genes were also not detected in 10 closely related mycobacterial strains and human genomic DNA.
CONCLUSIONS: The present MPCR method is highly specific and can detect M. paratuberculosis DNA more reliably. These findings do not support an aetiologic role of M. paratuberculosis in Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9282975     DOI: 10.3109/00365529708996540

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

1.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

2.  Results of multiple diagnostic tests for Mycobacterium avium subsp. paratuberculosis in patients with inflammatory bowel disease and in controls.

Authors:  M T Collins; G Lisby; C Moser; D Chicks; S Christensen; M Reichelderfer; N Høiby; B A Harms; O O Thomsen; U Skibsted; V Binder
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  PCR detection of Mycobacterium paratuberculosis in Crohn's disease granulomas isolated by laser capture microdissection.

Authors:  P Ryan; M W Bennett; S Aarons; G Lee; J K Collins; G C O'Sullivan; J O'Connell; F Shanahan
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

Review 4.  Mycobacterium avium subspecies paratuberculosis causes Crohn's disease in some inflammatory bowel disease patients.

Authors:  Saleh A Naser; Sudesh R Sagramsingh; Abed S Naser; Saisathya Thanigachalam
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

5.  Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease and ulcerative colitis.

Authors:  Charles N Bernstein; James F Blanchard; Patricia Rawsthorne; Michael T Collins
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

6.  Study of animal-borne infections in the mucosas of patients with inflammatory bowel disease and population-based controls.

Authors:  Charles N Bernstein; Gopi Nayar; Andre Hamel; James F Blanchard
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

Review 7.  The zoonotic potential of Mycobacterium avium ssp. paratuberculosis: a systematic review and meta-analyses of the evidence.

Authors:  L A Waddell; A Rajić; K D C Stärk; S A McEWEN
Journal:  Epidemiol Infect       Date:  2015-05-20       Impact factor: 4.434

8.  IL-12Rβ1 deficiency corresponding to concurrency of two diseases, mendelian susceptibility to mycobacterial disease and Crohn's disease.

Authors:  Razieh Khoshnevisan; Nioosha Nekooei-Marnany; Christoph Klein; Daniel Kotlarz; Mahdieh Behnam; Vajihe Ostadi; Majid Yaran; Abbas Rezaei; Roya Sherkat
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2019-09-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.